In order to examine whether Tregs also suppress effector functions in lean and obese IL-6Rα-deficient mice in our CAC model, anti-CD25 antibody was i.p. injected at day 3 of the 1.5% AOM/DSS protocol just prior to the colitis phase of CAC. This evidence concerns the gene IL2RA and colitis.